Polygalacic acid

CAS No. 22338-71-2

Polygalacic acid( —— )

Catalog No. M18257 CAS No. 22338-71-2

Polygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 58 In Stock
5MG 104 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Polygalacic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Polygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity.
  • Description
    Polygalacic acid(PA) significantly improves cholinergic system reactivity, as indicated by decreased acetylcholinesterase (AChE) activity, increases choline acetyltransferase (ChAT) activity, and elevates levels of acetylcholine (ACh) in the hippocampus and frontal cortex, PA also significantly ameliorates neuroinflammation and oxidative stress in mice; suggest that PA might exert a significant neuroprotective effect on cognitive impairment, driven in part by the modulation of cholinergic activity and neuroinflammation. Polygalacic acid shows significant postingestive effects on Spodoptera littoralis larvae.
  • In Vitro
    Polygalacic acid (0-100 μM; 24 hours) significantly decreases the mRNA expressions of MMP-3, MMP-9, MMP-13, and COX-2, which are significantly increased by IL-1β, in a dose-dependent manner.Polygalacic acid (0-100 μM; 6 hours) decreases the expression of phosphor-p38, phosphor-Erk, and phosphor-Jnk induced by IL-1β, phosphor-p65 is not reduced by polygalacic acid. RT-PCR Cell Line:Chondrocyte cells Concentration:50 μM; 100 μM Incubation Time:24 hours Result:Suppressed IL-1β-induced COX-2, MMP3, MMP9, and MMP13 mRNA expression.Western Blot Analysis Cell Line:Chondrocyte cells Concentration:50 μM; 100 μM Incubation Time:6 hours Result:Inhibited the IL-1β-induced activation of the MAPK pathway in chondrocytes.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Lipoxygenase
  • Recptor
    AChR
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    22338-71-2
  • Formula Weight
    504.7
  • Molecular Formula
    C30H48O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (99.07 mM)
  • SMILES
    O=C(O)[C@]53CCC(C)(C)C[C@H]5C4=CC[C@H]2[C@@](C)(CC[C@@H]1[C@]2(C)C[C@H](O)[C@H](O)[C@@]1(C)CO)[C@]4(C)C[C@H]3O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Choi YH1, Yoo DS, Cha MR, Choi CW, Kim YS, Choi SU, Lee KR, Ryu SY. J Nat Prod. 2010 Nov 29;73(11)
molnova catalog
related products
  • 1-Naphthyl 3,5-dinit...

    1-Naphthyl 3,5-dinitrobenzoate is an inhibitor of 5-LOX can be used in studies about inflammatory therapy.

  • CAY10698

    CAY10698 is a 12-lipoxygenase inhibitor (12-LO; IC50 of 5.1 μM).

  • CJ-13610

    CJ-13610 is a potent 5-Lipoxygenase (5-LO) inhibitor that suppresses 5-LO product formation with IC50 of 70 nM.